Drug Type Chemical drugs |
Synonyms EP-0226 |
Target |
Action modulators |
Mechanism Cav2.2 modulators(Voltage-gated N-type calcium channel alpha-1B subunit modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 2/3 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Herpes Zoster | Phase 3 | China | 09 Oct 2026 | |
| Herpes Zoster | Phase 3 | China | 09 Oct 2026 | |
| Herpes Zoster | Phase 3 | China | 09 Oct 2026 | |
| Neuralgia | Phase 3 | China | 09 Oct 2026 | |
| Neuralgia | Phase 3 | China | 09 Oct 2026 | |
| Neuralgia | Phase 3 | China | 09 Oct 2026 |





